No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).
Now, the same team has developed a monoclonal antibody that blocks the nitration sites of HGF, effectively preventing the protein's age induced loss of function. Their findings were validated ...
All other infusion-related and hypersensitivity reactions were mild or moderate. Covid-19 monoclonal antibodies are needed to protect immunocompromised persons who may not mount an adequate ...
The team noted that the antibody selectively targets cells with elevated CD84 levels, sparing healthy immune cells, which express this protein at lower levels, Xinhua news agency reported.